Associate Professor Mastura Monif
@MasturaMonif
Followers
1K
Following
5K
Media
54
Statuses
1K
Neurologist, Neuroscientist. Head of Neuroimmunology, Neuroinflammation, Neurooncology Lab @MonashUni. Deputy Director, MS & Neuroimmunology @AlfredHealth.
Joined September 2018
1/2 .Research can sometimes be hard, but it's the people that make it all worthwhile. Could not have asked for a better team. 2024/2025 Neuroimmunology Neuroinflammation and Neurooncology (N3; Monif lab). @STMneurosci
1
0
20
Hot off the press today, check out our super talented PhD student, Christina Kazzi's paper: How a simple clock drawing test can complement current #ICANS assessment in #CART patients. Well done Christina! đź‘Ź . @MonashSTM.@AlfredHealth CART program.
onlinelibrary.wiley.com
Immune effector cell-associated neurotoxicity syndrome (ICANS)-associated cognitive impairment is common in patients who receive chimeric antigen receptor T-cell (CAR-T) therapy. This study evaluat...
0
0
2
RT @TheLancet: Nearly half of dementia cases could be prevented or delayed by tackling 14 risk factors starting in childhood, including two….
0
300
0
RT @NatureCancer: 🌟Another timely Review @NatureCancer, by G. Dotti and collaborators 👇.
nature.com
Nature Cancer - Dotti and colleagues review chimeric antigen receptor (CAR)-engineered cell-based cancer therapy and overview its transition for solid tumors from CAR T to CAR-engineered innate...
0
28
0
Hot off the press today, check out Dr Nabil Seery's paper @GreenJournal. #LGI1 #AE.#AAEC.#N3Lab.@MonashSTM. Acute and Long-Term Immune-Treatment Strategies in Anti-LGI1 Antibody–Mediated Encephalitis | Neurology Neuroimmunology & Neuroinflammation
neurology.org
Background and ObjectivesFew studies have evaluated acute immunotherapy and relapse prevention strategies in patients with anti–leucine-rich glioma-inactivated 1 (LGI1) antibody (Ab)–mediated...
0
6
11
RT @NatureBiotech: CD8-targeted lipid nanoparticles carrying anti-CD19 CAR mRNA were developed to generate CAR-T cells directly in vivo, de….
science.org
Chimeric antigen receptor (CAR) T cell therapies have transformed treatment of B cell malignancies. However, their broader application is limited by complex manufacturing processes and the necessity...
0
67
0
Well done to Dr Nabil Seery presenting his post-doctoral work on MRI changes in #AutoimmuneEncephalitis. Well done Nabil! đź‘Ź. @MonashSTM .#AAEC study
0
0
2
Well done to our PhD student Christina Kazzi presenting her work on #CART related neurotoxicity at #anzan2025. Well done Christina!! đź‘Ź . @MonashSTM @AlfredHealth
0
0
4
RT @Brandon_Beaber: Potential new therapies for MS (CAR-T cells, BTKIs, HSCT, remyelination, high dose b-cell depleters) and the newly unde….
0
27
0
RT @NatRevRheumatol: New content online: Clonal dominance: mutations in VEXAS syndrome take advantage of inflammation .
0
29
0
RT @simocristea: engineering T cells within the body of the patient (rather than in a lab) is the next frontier for cancer immunotherapy ht….
0
56
0
Our super talented PhD student Christina Kazzi presenting at the .@MonashSTM_GRSC symposium. Well done Christina! đź‘Źđź‘Źđź‘Ź. @MonashSTM
0
0
1
We have two very exciting fellowship positions in MS, Neuroimmunology, CART @AlfredHealth in 2026. The fellowships combine with a PhD. Links below. These are for AHPRA registered neurology advanced trainees.
livehire.com
Alfred Health • 2025 position available for 12 months for a Neuroimmunology Fellow in the CAR-T Cell Therapy program. This role has the key responsibility for co-ordinating and participating in the...
0
1
3
2/2 We are very grateful to all our collaborators as part of the #AustralianAutoimmuneEncephalitisConsortium. @MonashSTM . And watch this space for a second paper in same journal on LGI1 AE in 2 weeks time. Well done Nabil đź‘Źđź‘Źđź‘Ź.
0
1
2
1/1 Hot off the press today, check out Dr Nabil Seery's paper @GreenJournal . #NMDAR #AE.#AAEC.#N3Lab. Rituximab Use for Relapse Prevention in Anti-NMDAR Antibody-Mediated Encephalitis | Neurology Neuroimmunology & Neuroinflammation
neurology.org
Background and ObjectivesRituximab is an anti-CD20 monoclonal antibody used in patients with anti-NMDAR antibody (Ab)-mediated encephalitis as both an acute escalation therapy and a longer term...
1
5
17
RT @LabWaggoner: CAR T cell therapy can cause cognitive impairment via persistent neuroinflammation that disrupts oligodendroglial homeosta….
0
43
0
RT @NatRevDrugDisc: For readers interested in approaches to reset the immune system to treat autoimmune diseases, here's a comprehensive re….
0
123
0
RT @NatRevNeurol: The multilayered transcriptional architecture of glioblastoma ecosystems
nature.com
Nature Genetics - Integrated single-cell transcriptomic and genetic characterization of 121 adult glioblastomas identifies heterogeneity at cell type, cell state and baseline expression program...
0
4
0